======= ATP11A =======
== Gene Information ==
* **Official Symbol**: ATP11A
* **Official Name**: ATPase phospholipid transporting 11A
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23250|23250]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P98196|P98196]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ATP11A&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ATP11A|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605868|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules (Probable). May be involved in the uptake of farnesyltransferase inhibitor drugs, such as lonafarnib. {ECO:0000269|PubMed:15860663, ECO:0000305}.
|Hydrolase|
|E1-E2 ATPase|
|HAD|
|ATPase-coupled intramembrane lipid transporter activity|
|phospholipid translocation|
|lipid translocation|
|regulation of membrane lipid distribution|
|tertiary granule membrane|
|specific granule membrane|
|phospholipid transport|
|recycling endosome|
|organophosphate ester transport|
|trans-Golgi network|
|magnesium ion binding|
|early endosome|
|lipid transport|
|lysosomal membrane|
|lipid localization|
|in utero embryonic development|
|organic anion transport|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|anion transport|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|intracellular membrane-bounded organelle|
|regulated exocytosis|
|leukocyte mediated immunity|
|exocytosis|
|membrane organization|
|leukocyte activation|
|embryo development|
|secretion by cell|
|endoplasmic reticulum|
|export from cell|
|cell activation|
|immune effector process|
|secretion|
|ion transport|
|ATP binding|
|immune response|
|vesicle-mediated transport|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.84|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16751
* **Expression level (log2 read counts)**: 7.79
{{:chemogenomics:nalm6 dist.png?nolink |}}